Clinical research into the diseases affecting newborns, children and adolescents is conducted at the Monash Children’s Hospital, Monash Health and the Department of Paediatrics, with basic research at The Ritchie Centre.
To ensure the best long term outcome for premature babies, it is very important to prevent or minimise the lung disease of prematurity, and brain damage from perinatal hypoxia or cerebral haemorrhage. Our key areas of translational research are in neuroprotective strategies and the prevention of lung disease through optimising non-invasive respiratory support, the timing of cord clamping, functional cardiac echocardiography and the management of pulmonary hypertension. Animal and clinical studies in the use of Melatonin to prevent brain damage from birth asphyxia are funded by the Gates Foundation. Vaccine safety research in pregnancy and childhood is funded by the World Health Organisation, US National vaccine Program Office, and Monash Health Foundation.
The Ritchie Centre (TRC) is the largest perinatal research centre in Australia and functions as a major research arm for the Department of Paediatrics. The Ritchie Centre has an annual research budget of about $10M. Academically, TRC enjoys an especially close relationship with Monash Newborn.
Our research focuses on immunology, cancer, infectious diseases, vaccine safety, sleep disorders, cystic fibrosis, inflammatory bowel disease, diabetes and the integration of databases in primary, secondary and tertiary care. The clinical research into diseases of childhood are funded by the NHMRC, philanthropic foundations, and industry grants. Clinical trials are conducted by Monash Kids Research in infectious diseases, immunisation, endocrinology, urology and neurology.